APP and Alzheimer disease: Editing of another point mutation that is also associated with the risk of Alzheimer’s disease—a substitution in the amyloid precursor protein (APP) gene—by means of the BE3 system reduced the amounts of Aβ40 and Aβ42 peptides in vitro by more than 20% (Guyon et al., 2021).